NCT06027047 (BASEL) is a clinical trial in Sleep Deprivation, sponsored by Raivotech.

Who is sponsoring NCT06027047?

NCT06027047 is sponsored by Raivotech.

What condition does NCT06027047 study?

NCT06027047 studies Sleep Deprivation, Sleep Hygiene, Sleepiness, Sleep Driving, Depression, Anxiety, Anxiety Disorders, Depressive Symptoms.

Is NCT06027047 still recruiting?

NCT06027047 is currently status unknown. Last updated 7 September 2023.

Last reviewed 2023-09-07 · How we verify

NCT06027047: BASEL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Breakthrough Anxiety and Sleep Evaluation Using Linked Devices and Smartphone Application Onar (BASEL)

Status unknown Last updated 7 September 2023

What this trial tests

trial in Sleep Deprivation in 50 participants. Status unknown.

Timeline

1 September 2023

Primary endpoint
31 December 2023

15 January 2024

Quick facts

Lead sponsor	Raivotech
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	1 September 2023
Primary completion	31 December 2023
Estimated completion	15 January 2024

Conditions studied

Sleep Deprivation — all drugs for Sleep Deprivation →
Sleep Hygiene — all drugs for Sleep Hygiene →
Sleepiness — all drugs for Sleepiness →
Sleep Driving — all drugs for Sleep Driving →

Sponsor

Raivotech

Who can join

Adults 18 to 60, any sex, with Sleep Deprivation or Sleep Hygiene. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sleep is not simply the absence of wakefulness. Sleep is an active procedure, normally happening every night, and is absolutely vital. Good sleep is essential for our well-being. Survival without food can be further than without sleep. Work time and commuting time seem to affect total sleep time and night bedtime. Social and work obligation can, therefore, suppress sleep time. Sleep deprived individuals may be facing anxiety and depression symptoms. The aim of this study is to investigate the presence of anxiety and depression symptoms among adults with the use of the smartphone application Onar. Onar app will be used to gather information from wearable devices of the users including total sleep time, sleep efficiency, wake after sleep onset time. An established questionnaire (Hospital Anxiety Depression Scale/ HADS) will be used to quantify and detect the presence of anxiety and depression in the study population.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sleep Deprivation

Currently open trials in the same condition.

NCT07438912 — Mind After Midnight · NA · recruiting
NCT07329283 — Nighttime Synchrony of Your Nutrition and Circadian Health · NA · recruiting
NCT07294781 — Circadian Rhythms and Time Perception in Healthy Adults During Constant Wakefulness · NA · recruiting
NCT07085754 — Effects of Acute Sleep Deprivation on Individuals With Different APOE Genotypes · NA · recruiting
NCT06492109 — The Peripheral Blood Multi-Omics Study on Sleep Loss · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06027047 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Raivotech
Last refreshed: 7 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06027047.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing